US2951540A
(en)
|
1956-11-05 |
1960-09-06 |
Gen Motors Corp |
Propeller brake
|
US3709898A
(en)
|
1971-02-09 |
1973-01-09 |
Upjohn Co |
Process for the production of triazolobenzodiazepines and intermediates
|
US3681343A
(en)
|
1971-05-11 |
1972-08-01 |
Upjohn Co |
6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines
|
US3812259A
(en)
|
1971-08-09 |
1974-05-21 |
Upjohn Co |
Animal feed and process
|
CH622019A5
(en)
|
1975-10-23 |
1981-03-13 |
Upjohn Co |
Process for the preparation of aminotriazolobenzodiazepines
|
FR2329668A1
(fr)
|
1975-10-27 |
1977-05-27 |
Upjohn Co |
Procede de preparation d'aminotriazolobenzodiazepines
|
EP0087850A1
(en)
|
1982-01-04 |
1983-09-07 |
The Upjohn Company |
Benzodiazepines for anti-hypertensive use
|
DE3435973A1
(de)
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
DE3724164A1
(de)
|
1986-07-25 |
1988-01-28 |
Boehringer Ingelheim Kg |
Neue 1,4-benzodiazepine, ihre herstellung und verwendung
|
ATE86256T1
(de)
|
1987-05-28 |
1993-03-15 |
Yoshitomi Pharmaceutical |
Thieno(triazolo)diazepinverbindungen, und medizinische verwendung derselben.
|
JPH0676326B2
(ja)
|
1988-05-24 |
1994-09-28 |
吉富製薬株式会社 |
循環器系疾患治療薬
|
EP0368175A1
(de)
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
EP0387613A1
(de)
|
1989-03-03 |
1990-09-19 |
Boehringer Ingelheim Kg |
Neue Thienodiazepine
|
EP0407955A1
(de)
|
1989-07-12 |
1991-01-16 |
Boehringer Ingelheim Kg |
Neue Hetrazepine mit PAF-antagonistischer Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE4010528A1
(de)
|
1990-04-02 |
1991-10-17 |
Boehringer Ingelheim Kg |
Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
|
US5593988A
(en)
|
1991-10-11 |
1997-01-14 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Therapeutic agent for osteoporosis and diazepine compound
|
WO1994006802A1
(en)
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienodiazepine compound and medicinal use thereof
|
WO1994022872A1
(en)
|
1993-03-30 |
1994-10-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Cell adhesion inhibitor and thienotriazolodiazepine compound
|
WO1995032963A1
(fr)
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienylazole et compose de thienotriazolodiazepine
|
BR9606823A
(pt)
|
1995-01-06 |
1997-12-30 |
Hoffmann La Roche |
Hidroximetil-imidazoazepinas e seus èsteres
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
JP3314938B2
(ja)
*
|
1995-06-06 |
2002-08-19 |
ファイザー・インコーポレーテッド |
グリコーゲンホスホリラーゼ抑制剤としての置換されたn−(インドール−2−カルボニル)−グリシンアミド類および誘導体
|
EP0832066B1
(en)
*
|
1995-06-06 |
2001-09-12 |
Pfizer Inc. |
Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
|
DK0853480T3
(da)
|
1995-09-09 |
2003-05-05 |
Hoffmann La Roche |
Anvendelse af en thienotriazolodiazepin til forøgelse af apolipoprotein A-I-niveauer
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
WO1997047622A1
(fr)
|
1996-06-12 |
1997-12-18 |
Japan Tobacco Inc. |
Inhibiteurs de production de cytokines, composes triazepine et intermediaires correspondants
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
ES2182108T3
(es)
|
1996-09-13 |
2003-03-01 |
Mitsubishi Pharma Corp |
Compuestos de tienotriazolodiazepina y usos medicinales de los mismos.
|
US6444664B1
(en)
|
1997-04-18 |
2002-09-03 |
Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) |
Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
|
JPH11228576A
(ja)
|
1997-12-10 |
1999-08-24 |
Japan Tobacco Inc |
アポトーシス抑制剤
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
FR2779652B1
(fr)
*
|
1998-06-15 |
2001-06-08 |
Sod Conseils Rech Applic |
Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
|
KR20000016732A
(en)
|
1998-12-12 |
2000-03-25 |
Japan Tobacco Inc |
Cytokine production inhibitors, triazepine compounds, and intermediates thereof
|
EP2042194A3
(en)
|
1999-05-14 |
2009-04-22 |
Imclone Systems, Inc. |
Treatment of refractory human tumors with epidermal growth factor receptor antagonists
|
US6312215B1
(en)
|
2000-02-15 |
2001-11-06 |
United Technologies Corporation |
Turbine engine windmilling brake
|
US7589167B2
(en)
|
2000-02-22 |
2009-09-15 |
J. David Gladstone Institutes |
ZA loops of bromodomains
|
JP4875277B2
(ja)
|
2000-06-16 |
2012-02-15 |
田辺三菱製薬株式会社 |
放出pH域及び/又は速度制御組成物
|
US6552037B2
(en)
|
2000-06-30 |
2003-04-22 |
Neurogen Corporation |
2-Substituted imidazo[1,2-A]pyridine derivatives
|
US20060142257A1
(en)
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
US6979682B2
(en)
|
2001-02-23 |
2005-12-27 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
|
US20030216758A1
(en)
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
EP1606268B1
(en)
|
2003-02-27 |
2015-05-20 |
AbbVie Inc. |
5,10-dihydro-11h-dibenzo[b,e][1,4]diazepin-11-one as kinase inhibitors
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
WO2005000335A2
(en)
*
|
2003-06-02 |
2005-01-06 |
Ohio University |
Use of genes differentially expressed during aging of liver for treatment and diagnosis
|
WO2005002526A2
(en)
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Method and compositions for treatment of viral infections
|
US20070105839A1
(en)
|
2003-09-18 |
2007-05-10 |
Patricia Imbach |
2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
US8624027B2
(en)
|
2005-05-12 |
2014-01-07 |
Abbvie Inc. |
Combination therapy for treating cancer and diagnostic assays for use therein
|
EP1887008B1
(en)
|
2005-05-30 |
2021-04-21 |
Mitsubishi Tanabe Pharma Corporation |
Thienotriazolodiazepine compound and a medicinal use thereof
|
WO2007014838A1
(en)
|
2005-08-03 |
2007-02-08 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones in the treatment of respiratory diseases
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
AU2006309013B2
(en)
|
2005-11-01 |
2012-06-28 |
Impact Biomedicines, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
TW200803842A
(en)
|
2005-11-04 |
2008-01-16 |
Wyeth Corp |
Antineoplastic combinations of temsirolimus and sunitinib malate
|
SI1962830T1
(sl)
|
2005-12-23 |
2013-07-31 |
Glaxosmithkline Llc |
Azaindolni inhibitorji kinaz Aurora
|
CA2636112A1
(en)
|
2006-01-17 |
2007-07-26 |
F.Hoffmann-La Roche Ag |
Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives useful for the treatment of alzheimer's disease via gaba receptors
|
TW200804389A
(en)
|
2006-02-14 |
2008-01-16 |
Vertex Pharma |
Dihydrodiazepines useful as inhibitors of protein kinases
|
US20070218135A1
(en)
|
2006-03-14 |
2007-09-20 |
Glenmark Pharmaceuticals Limited |
Sustained release matrix pharmaceutical composition
|
KR20090005137A
(ko)
|
2006-05-03 |
2009-01-12 |
노파르티스 아게 |
유기 화합물의 용도
|
US7621117B2
(en)
|
2006-06-19 |
2009-11-24 |
Pratt & Whitney Canada Corp. |
Apparatus and method for controlling engine windmilling
|
CN105693730A
(zh)
|
2006-10-19 |
2016-06-22 |
西格诺药品有限公司 |
杂芳基化合物、其组合物以及它们作为蛋白激酶抑制剂的用途
|
WO2008066887A2
(en)
|
2006-11-30 |
2008-06-05 |
Albert Einstein College Of Medicine Of Yeshiva University |
Small molecule inhibitors of bcl6
|
KR20170102580A
(ko)
|
2006-12-26 |
2017-09-11 |
랜티우스 메디컬 이메징, 인크. |
심장 신경 분포의 영상화를 위한 리간드
|
JP2008156311A
(ja)
|
2006-12-26 |
2008-07-10 |
Institute Of Physical & Chemical Research |
Brd2ブロモドメイン結合剤
|
WO2008137081A1
(en)
|
2007-05-02 |
2008-11-13 |
The Trustees Of Columbia University In The City Of New York |
Substituted ( 5, 6 ) -dihydronaphraalenyl compounds as reversible male contraceptives
|
KR20080107050A
(ko)
|
2007-06-05 |
2008-12-10 |
울산대학교 산학협력단 |
항-cd137 단일클론 항체를 포함하는 만성이식편대숙주 질환의 예방 또는 치료용 약학적 조성물
|
WO2009080638A2
(en)
|
2007-12-20 |
2009-07-02 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
EP2233966B1
(en)
*
|
2007-12-28 |
2013-10-23 |
Nippon Telegraph and Telephone Corporation |
Method of variably converging or diverging light using a variable focal lenght lens
|
CA2710740C
(en)
|
2007-12-28 |
2016-07-19 |
Shinji Miyoshi |
Thienotriazolodiazepine compound as antitumor agent
|
EP2276747A1
(en)
|
2008-03-11 |
2011-01-26 |
Cellzome Limited |
Sulfonamides as zap-70 inhibitors
|
WO2010015340A1
(en)
|
2008-08-06 |
2010-02-11 |
Bayer Schering Pharma Aktiengesellschaft |
Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
|
EA018620B1
(ru)
|
2008-10-30 |
2013-09-30 |
Сёркомед Ллк |
ПРОИЗВОДНЫЕ ТИЕНОТРИАЗОЛОДИАЗЕПИНА, АКТИВНЫЕ В ОТНОШЕНИИ Apo A1
|
US9266890B2
(en)
|
2009-01-06 |
2016-02-23 |
Dana-Farber Cancer Institute, Inc. |
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
|
US7928105B2
(en)
|
2009-01-23 |
2011-04-19 |
Takeda Pharmaceutical Company Limited |
Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
AU2010314395B2
(en)
|
2009-11-05 |
2015-04-09 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
DK2496582T3
(en)
|
2009-11-05 |
2016-03-21 |
Glaxosmithkline Llc |
Benzodiazepine-BROMDOMAeNEINHIBITOR.
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
US8862173B2
(en)
|
2009-12-10 |
2014-10-14 |
Motorola Solutions, Inc. |
Method for selecting media for delivery to users at an incident
|
WO2011101369A1
(en)
|
2010-02-17 |
2011-08-25 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones, method for production and use thereof
|
US9624870B2
(en)
|
2010-03-26 |
2017-04-18 |
Rolls-Royce North American Technologies, Inc. |
Adaptive fan system for a variable cycle turbofan engine
|
JP5715241B2
(ja)
|
2010-05-14 |
2015-05-07 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
|
CN103180318B
(zh)
|
2010-05-14 |
2017-05-10 |
达那-法伯癌症研究所 |
雄性避孕组合物以及使用方法
|
PL2902030T3
(pl)
|
2010-05-14 |
2017-07-31 |
Dana-Farber Cancer Institute, Inc. |
Związki tienotriazolodiazepinowe do leczenia nowotworu
|
JP5913292B2
(ja)
*
|
2010-05-14 |
2016-04-27 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
代謝を調節する組成物および方法
|
CN103154246B
(zh)
|
2010-05-14 |
2015-11-25 |
达那-法伯癌症研究所 |
用于治疗白血病的组合物和方法
|
ES2526671T3
(es)
|
2010-06-22 |
2015-01-14 |
Glaxosmithkline Llc |
Compuestos de benzotriazoldiazepina inhibidores de bromodominios
|
CA2805413A1
(en)
|
2010-06-25 |
2011-12-29 |
Shire Human Genetic Therapies, Inc. |
Methods and compositions for cns delivery of heparan n-sulfatase
|
US20120014979A1
(en)
|
2010-07-16 |
2012-01-19 |
Alexander Dent |
Use of bcl6 inhibitors for treating autoimmune diseases
|
TWI583689B
(zh)
|
2010-08-04 |
2017-05-21 |
達納 法柏癌症學院有限公司 |
治療腫瘤形成、發炎疾病及其他病症之組成物及方法
|
EP2621282B1
(en)
*
|
2010-09-28 |
2020-04-15 |
The Regents of The University of California |
Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
US20130004481A1
(en)
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
US20140066410A1
(en)
|
2011-02-23 |
2014-03-06 |
Icahn School Of Medicine At Mount Sinai |
Inhibitors of bromodomains as modulators of gene expression
|
WO2012118812A2
(en)
|
2011-02-28 |
2012-09-07 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
CA2864394C
(en)
|
2011-03-02 |
2021-10-19 |
Jack Roth |
A method of predicting a response to a tusc2 therapy
|
JP2014524409A
(ja)
|
2011-07-29 |
2014-09-22 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
Hivの治療のための組成物および方法
|
FI20110279A0
(fi)
|
2011-08-29 |
2011-08-29 |
Outotec Oyj |
Menetelmä metallien talteenottamiseksi niitä sisältävästä materiaalista
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
WO2013033270A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
|
WO2013033420A1
(en)
|
2011-08-30 |
2013-03-07 |
Whitehead Institute For Biomedical Research |
Methods of downregulating translocated oncogene expression using bromodomain inhibitors
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
JP2015508780A
(ja)
|
2012-02-17 |
2015-03-23 |
アンサン バイオファーマ,インコーポレイテッド |
免疫不全患者のインフルエンザ及びパラインフルエンザウイルスを処置するための方法、化合物、及び組成物
|
US20150133434A1
(en)
|
2012-03-28 |
2015-05-14 |
The J. David Gladstone Institutes |
Compositions and Methods for Reactivating Latent Immunodeficiency Virus
|
EP2861255B1
(en)
|
2012-06-19 |
2019-10-09 |
The Broad Institute, Inc. |
Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
|
KR20150100613A
(ko)
|
2012-09-28 |
2015-09-02 |
온코에틱스 게엠베하 |
티에노트리아졸로디아제핀 화합물을 함유하는 약제학적 제제
|
EP2917203B1
(en)
|
2012-11-02 |
2019-04-03 |
Dana-Farber Cancer Institute, Inc. |
Method for identifying myc inhibitors
|
EP2958922A1
(de)
|
2013-02-22 |
2015-12-30 |
Bayer Pharma Aktiengesellschaft |
Pyrrolo- und pyrazolo-triazolodiazepine als bet-proteininhibitoren zur behandlung von hyper-proliferativen erkrankungen
|
WO2014128111A1
(de)
|
2013-02-22 |
2014-08-28 |
Bayer Pharma Aktiengesellschaft |
4-substituierte pyrrolo- und pyrazolo-diazepine
|
AU2014223990A1
(en)
|
2013-02-28 |
2015-09-10 |
Washington University |
Methods of treatment of human cytomegalovirus infection and diseases with bromodomain inhibitors
|
WO2014159392A1
(en)
|
2013-03-14 |
2014-10-02 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
RU2015144185A
(ru)
|
2013-03-15 |
2017-04-26 |
Дженентек, Инк. |
Лечение заболеваний, опосредованных тh2, путем ингибирования бромодоменов
|
JP2016520130A
(ja)
|
2013-05-28 |
2016-07-11 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
心臓疾患における新規治療戦略としてのbet阻害
|
DE102013106353B4
(de)
|
2013-06-18 |
2018-06-28 |
Tdk Corporation |
Verfahren zum Aufbringen einer strukturierten Beschichtung auf ein Bauelement
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
EP3030242A1
(en)
|
2013-08-06 |
2016-06-15 |
Oncoethix GmbH |
Method of treating diffuse large b-cell lymphoma (dlbcl) using a bet-bromodomain inhibitor
|
WO2015018522A1
(en)
|
2013-08-06 |
2015-02-12 |
Oncoethix Sa |
Bet-bromodomain inhibitor shows synergism with several anti-cancer agents in pre-clinical models of diffuse large b-cell lymphoma (dlbcl)
|
EP3033423A4
(en)
|
2013-08-16 |
2017-04-26 |
Rana Therapeutics Inc. |
Epigenetic regulators of frataxin
|
US8988212B2
(en)
|
2013-08-22 |
2015-03-24 |
GM Global Technology Operations LLC |
Electric vehicle pedestrian warning system
|
JP6663852B2
(ja)
|
2013-09-19 |
2020-03-13 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Bh3プロファイリングの方法
|
JP2016534044A
(ja)
|
2013-10-11 |
2016-11-04 |
ジェネンテック, インコーポレイテッド |
癌の免疫療法のためのcbp/ep300ブロモドメインインヒビターの使用
|
RU2016122654A
(ru)
|
2013-11-08 |
2017-12-14 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка
|
WO2015081284A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
EP3099696A4
(en)
|
2014-01-31 |
2017-07-05 |
Dana-Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
US10150756B2
(en)
|
2014-01-31 |
2018-12-11 |
Dana-Farber Cancer Institute, Inc. |
Diaminopyrimidine benzenesulfone derivatives and uses thereof
|
KR20160130778A
(ko)
|
2014-02-28 |
2016-11-14 |
텐샤 세러퓨틱스 인코포레이티드 |
고인슐린혈증과 관련된 질환의 치료
|
KR20170068597A
(ko)
|
2014-10-27 |
2017-06-19 |
텐샤 세러퓨틱스 인코포레이티드 |
브로모도메인 저해제
|
US10813939B2
(en)
|
2014-12-05 |
2020-10-27 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Bromodomain inhibitor as adjuvant in cancer immunotherapy
|
BR112017028178A2
(pt)
|
2015-06-26 |
2018-08-28 |
Tensha Therapeutics Inc |
tratamento de carcinoma de linha média nut
|
CN108289957A
(zh)
|
2015-10-02 |
2018-07-17 |
达纳-法伯癌症研究所股份有限公司 |
溴区结构域抑制剂和检查点阻断的组合疗法
|